ScholarIQanswers from OpenAlex

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis

PaperCitations, authors & open-access status

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis have?

ScholarIQcitation count

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis has 191 citations in the OpenAlex counts ScholarIQ stores.

When was Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis published?

ScholarIQyear

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis has 2010 year in the ScholarIQ index.

What is the open-access status of Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis?

ScholarIQoa status

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis has closed oa status in the ScholarIQ index.

What is the DOI of Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis?

ScholarIQdoi

The DOI for Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis is on the source record.

What is the PMID of Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis?

ScholarIQpmid

The PMID for Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis is on the source record.

What is the OpenAlex record for Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis?

ScholarIQopenalex

The OpenAlex for Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial